Outpatient High‐Dose Urokinase Infusion Improves Dialysis Catheter Longevity: A Prospective Observational Study
dc.contributor.author | Saran, Rajiv | |
dc.contributor.author | Venkataraman, Vijaya | |
dc.contributor.author | Leavey, Sean F. | |
dc.contributor.author | Usovsky, Ron | |
dc.contributor.author | Usha, Kumari | |
dc.contributor.author | Twardowski, Zbylut J. | |
dc.date.accessioned | 2016-10-17T21:19:50Z | |
dc.date.available | 2016-10-17T21:19:50Z | |
dc.date.issued | 2000-01 | |
dc.identifier.citation | Saran, Rajiv; Venkataraman, Vijaya; Leavey, Sean F.; Usovsky, Ron; Usha, Kumari; Twardowski, Zbylut J. (2000). "Outpatient High‐Dose Urokinase Infusion Improves Dialysis Catheter Longevity: A Prospective Observational Study." Hemodialysis International 4(1): 32-36. | |
dc.identifier.issn | 1492-7535 | |
dc.identifier.issn | 1542-4758 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/134242 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.subject.other | Hemodialysis catheter | |
dc.subject.other | malfunction | |
dc.subject.other | thrombosis | |
dc.subject.other | urokinase | |
dc.subject.other | warfarin | |
dc.title | Outpatient High‐Dose Urokinase Infusion Improves Dialysis Catheter Longevity: A Prospective Observational Study | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, Michigan, U.S.A. | |
dc.contributor.affiliationother | University of Missouri–Columbia, Columbia, Missouri, U.S.A. | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/134242/1/hdi20004132.pdf | |
dc.identifier.doi | 10.1002/hdi.2000.4.1.32 | |
dc.identifier.source | Hemodialysis International | |
dc.identifier.citedreference | Uldall R, Besley ME, Thomas A, Salter S, Nuezca LA, Vas M. Maintaining the patency of double-lumen silastic jugular catheters for hemodialysis. Int J Artif Organs. 16: 37 – 40, 1993. | |
dc.identifier.citedreference | Schwab SJ, Beathard G. The hemodialysis catheter conundrum: Hate living with them, but can’t live without them. Kidney Int. 56: 1 – 17, 1999. | |
dc.identifier.citedreference | Schwab S, Besarab A, Beathard G, Brouwer D, Etheredge E, Hartigan M, Levine M, McCann R, Sherman R, Trerotola S. National Kidney Foundation – Dialysis Outcomes Quality Initiative clinical practice guidelines for vascular access. Guideline 3: Selection of permanent vascular access and order of preference for placement of AV fistulae. Am J Kidney Dis. 30 ( suppl 3 ): S156 – 7, 1997. | |
dc.identifier.citedreference | Riordan S, Frawley J, Gray L, Niesche J. Primary access surgery for long-term hemodialysis. Aust N Z J Surg. 64: 763 – 7, 1994. | |
dc.identifier.citedreference | Windus DW, Jendrisak MD, Delmez JA. Prosthetic fistula survival and complications in hemodialysis patients: Effect of diabetes and age. Am J Kidney Dis. 19: 448 – 52, 1992. | |
dc.identifier.citedreference | Hoshal VL Jr, Ause RG, Hoskins PA. Fibrin sleeve formation on indwelling subclavian central venous catheters. Arch Surg. 102: 253 – 8, 1971. | |
dc.identifier.citedreference | Ash SR, Mankus RA, Sutton JM, Criswell RE, Crull RC, White LE, Lowrey SJ. Concentrated citrate for catheter lock solution (Abstract). J Am Soc Nephrol. 10: 272A, 1999. | |
dc.identifier.citedreference | Twardowski ZJ. High-dose intradialytic urokinase to restore patency of permanent central vein hemodialysis catheters. Am J Kidney Dis. 31: 841 – 7, 1998. | |
dc.identifier.citedreference | Twardowski ZJ. The clotted central venous catheter for haemodialysis. Nephrol Dial Transplant. 13: 2203 – 6, 1998. | |
dc.identifier.citedreference | Twardowski Z. Stepwise anticoagulation with warfarin for prevention of intravenous catheter thrombosis. Hemodial Int. 4: 37 – 41, 2000. | |
dc.identifier.citedreference | Seddon PA, Hrinya MK, Gaynord MA, Lion CM, Mangold BM, Bruns FJ. Effectiveness of low dose urokinase on dialysis catheter thrombolysis. ASAIO J. 44: M559 – M561, 1998. | |
dc.identifier.citedreference | Schwab SJ, Buller GL, McCann RL, Bollinger RR, Stickel DL. Prospective evaluation of a Dacron cuffed hemodialysis catheter for prolonged use. Am J Kidney Dis. 11: 166 – 9, 1988. | |
dc.identifier.citedreference | Twardowski ZJ. Percutaneous blood access for hemodialysis. Semin Dial. 8: 175 – 86, 1995. | |
dc.identifier.citedreference | Bour ES, Weaver AS, Yang HC, Gifford RR. Experience with the double lumen Silastic catheter for hemoaccess. Surg Gynecol Obstet. 171: 33 – 9, 1990. | |
dc.identifier.citedreference | Lund GB, Trerotola SO, Scheel PF Jr, Savader SJ, Mitchell SE, Venbrux AC, Osterman FA Jr. Outcome of tunneled hemodialysis catheters placed by radiologists. Radiology. 198: 467 – 72, 1996. | |
dc.identifier.citedreference | Trerotola SO, Johnson MS, Harris VJ, Shah H, Ambrosius WT, McKusky MA, Kraus MA. Outcome of tunneled hemodialysis catheters placed via the right internal jugular vein by interventional radiologists. Radiology. 203: 489 – 95, 1997. | |
dc.identifier.citedreference | Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PN, Arkin CF, Greco FA, Huberman M, Moore C. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med. 112: 423 – 8, 1990. | |
dc.identifier.citedreference | Boraks P, Seale J, Price J, Bass G, Ethell M, Keeling D, Mahendra P, Baglin T, Marcus R. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol. 101: 483 – 6, 1998. | |
dc.identifier.citedreference | Veerabagu MP, Tuttle–Newhall J, Maliakkal R, Champagne C, Mascioli EA. Warfarin and reduced central venous thrombosis in home total parenteral nutrition patients. Nutrition. 11: 142 – 4, 1995. | |
dc.identifier.citedreference | Pierratos A. Nocturnal home hemodialysis: An update on a 5-year experience. Nephrol Dial Transplant. 14: 2835 – 40, 1999. | |
dc.identifier.citedreference | Davenport A. Central venous catheters for hemodialysis: How to overcome the problems. Hemodial Int. 4: 78 – 82, 2000. | |
dc.identifier.citedreference | Atkinson JB, Bagnall HA, Gomperts E. Investigational use of tissue plasminogen activator (t-PA) for occluded central venous catheters. JPEN J Parenter Enteral Nutr. 14: 310 – 11, 1990. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.